Pfizer said it will wring another $500 million from legacy operating expenses, with cuts to its sales, R&D budgets bringing the total savings to $4 billion.
Sanofi CEO: Drugmaker has stocked pipeline but must win over investors
Ellipses Pharma has invested $150 million into its clinical drugs pipeline with plans to invest another $100 million, of which $40 million has already been raised.
FTX bankruptcy saga causing stress among investors, study finds